| |JUNE 20264Pharma CDMOs in India have brought forth a strategic shift in the ever-important drug development process for pharma companies. Today, Indian CDMOs are evolving beyond the traditional model to stay relevant with the changing market dynamics leveraging the proven CDMO 2.0 model. These players today are not just mere contract developers and manufacturers, but rather have evolved into more strategic, tech-agnostic partners offering a one-stop solution.Similarly, the India oncology clinical trials market generated USD 571.8 million in 2025 and is projected to reach USD 1,337.5 million by 2033, growing at a robust CAGR of 11.4 percent starting in 2026. This rapid expansion has been ramping up an unprecedented demand for specialized pharmaceutical oncology clinical research consulting. At the same time, the Pharma Clinical Research Services (CRO) market in India is experiencing rapid expansion and is projected to cross USD 3.6 billion in the coming years. This growth is being steered by the growing emphasis on prioritizing technological integration, data management, and domestic biopharma capability.Transitioning from traditional volume-based generics to value-driven, complex therapeutics, the pharmaceutical strategy advisory consulting market in India is undergoing a major shift in 2026 with a growing focus on R&D acceleration, digital health integration, and biosimilar commercializationAs these specialized niches in the realm of pharmaceuticals have been redefining the industry at a larger scale, India is poised to showcase tremendous growth potential as it solidifies itself as the global pharmaceutical hub that will play a pivotal role in driving the much needed innovation. Recognizing the importance of CDMOs, laboratory equipment supplier, oncology clinical research consultants, and strategic advisors, India Pharma Outlook brings to you our yet another meticulously crafted "June Edition VOL. II - 2026."Shiwani Pradhan Assistant Editoreditor@indiapharmaoutlook.comSetting Benchmarks in India's Burgeoning Realm of Pharma Vol 5 · Issue 04 - 06 · JUNE, 2026Publisher Alok ChaturvediManaging EditorSamrat Pradhan Assistant EditorShiwani Pradhan Editorial TeamViswanathan AThiruamuthan T K GM - Media & Graphic Designing VisualizerPrabhu DuttaDesignerVayshnavi pdAdvertising QueriesSakshath K TGM Sales & MarketingRavi Kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 250 per issuePrinted and Published By Alok Chaturvedi on behalf of Info Connect Web Technologies India Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2026 Info Connect Web Technologies India Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
< Page 3 | Page 5 >